Acute oral candidiasis during febrile episodes in immunocompromised patients with haematologic malignancies.
To estimate clinical, pathogenic and serological aspects of acute oral candidiasis (AOC) during febril episodes in patients with haematologic malignancies, 23 consecutive patients who developed AOC within 7 days from start of fever were compared with 23 consecutive patients who did not develop AOC. The duration of fever and severe granulocytopenia (less than 0.5 x 10(9)/l) was significantly longer in patients with AOC than in patients without AOC, the median differences between the patients with and without AOC being 4 and 3 days, respectively. Development of AOC could not be correlated to a change in the qualitative composition of the oral microflora. The thrombocyte count was lower in patients with AOC on day 4, whereas no differences were found in leukocyte counts. The prevalences of Candida albicans agglutinin titres greater than or equal to 5 were similar in patients with (24%) and without AOC (33%), and in controls (29%). Seroconversion or a significant increase in the agglutinin titre occurred in 4 patients with AOC and long-lasting fever, who became afebrile after systemic antifungal therapy. It is concluded that AOC is associated with long-lasting fever and decreased bone marrow function as judged by low thrombocyte counts, but not related to specific bacteria in the oral cavity or to an increased occurrence of C. albicans antibodies in the serum.
University Department of Medicine and Haematology, Aarhus Amtssygehus, Denmark.
O J
OJ
Bergmann
P L
PL
Andersen
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000150:complications; D000908:Antibodies, Fungal / Q000096:biosynthesis; D002176:Candida albicans / Q000276:immunology; D002180:Candidiasis, Oral / Q000097:blood / Q000209:etiology* / Q000276:immunology; D005334:Fever; D006801:Humans; D007108:Immune Tolerance; D007938:Leukemia / Q000150:complications*; D007958:Leukocyte Count; D008875:Middle Aged; D010976:Platelet Count; D011446:Prospective Studies; D018805:Sepsis / Q000150:complications
D000908:Antibodies, Fungal